These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 34074474)
21. COVID-19 and Neurology: An Emerging Association. Gupta A; Yadav P; Kumar D Infect Disord Drug Targets; 2021; 21(8):e160921191570. PubMed ID: 33602080 [TBL] [Abstract][Full Text] [Related]
22. [Immune-mediated encephalitis in a child with a history of SARS-CoV-2 infection]. Adauto Luizaga J; Costa Almar F; Zwirner A; Fernández Polivanoff ML; Suárez RF; Rossi S; Pascual C Arch Argent Pediatr; 2022 Aug; 120(4):e183-e186. PubMed ID: 35900960 [TBL] [Abstract][Full Text] [Related]
23. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial. Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494 [TBL] [Abstract][Full Text] [Related]
24. Neurological manifestations of COVID-19: A brief review. Sachdev K; Agrawal S; Ish P; Gupta N; Raheja K Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):41-47. PubMed ID: 32859864 [TBL] [Abstract][Full Text] [Related]
25. Emerging neurotropic features of SARS-CoV-2. Zhan WR; Huang J; Zeng PM; Tian WY; Luo ZG J Mol Cell Biol; 2021 Dec; 13(10):705-711. PubMed ID: 34289037 [TBL] [Abstract][Full Text] [Related]
26. Neurologic manifestations in children with COVID-19 from a tertiary center in Turkey and literature review. Laçinel Gürlevik S; Günbey C; Ozsurekci Y; Oygar PD; Kesici S; Gocmen R; Aydin O; Temucin Ç; Tufan E; Terzi K; Baltu D; Ozturk TT; Teksam O; Ozen S; Oguz KK; Cengiz AB; Yalnızoglu D Eur J Paediatr Neurol; 2022 Mar; 37():139-154. PubMed ID: 35287009 [TBL] [Abstract][Full Text] [Related]
27. Immune-mediated neurological syndrome in SARS-CoV-2 infection: a review of literature on autoimmune encephalitis in COVID-19. Payus AO; Jeffree MS; Ohn MH; Tan HJ; Ibrahim A; Chia YK; Raymond AA Neurol Sci; 2022 Mar; 43(3):1533-1547. PubMed ID: 34853897 [TBL] [Abstract][Full Text] [Related]
28. Parkinson disease following COVID-19: Report of six cases. Calculli A; Bocci T; Porcino M; Avenali M; Casellato C; Arceri S; Regalbuto S; Priori A; Pisani A Eur J Neurol; 2023 May; 30(5):1272-1280. PubMed ID: 36807419 [TBL] [Abstract][Full Text] [Related]
30. [COVID-19: neurological manifestations : What we know so far]. Yilmaz U; Lepper PM; Reith W Radiologe; 2020 Oct; 60(10):916-918. PubMed ID: 32880004 [TBL] [Abstract][Full Text] [Related]
31. A case report of encephalitis induced by SARS-CoV-2 confirmed by etiology: first case in Qingdao, China. Bi Q; Gu H; Qu M; Li Z; Mu X; Zhang L J Neurovirol; 2023 Jun; 29(3):350-354. PubMed ID: 37184750 [TBL] [Abstract][Full Text] [Related]
32. Cerebrospinal fluid in COVID-19: A systematic review of the literature. Lewis A; Frontera J; Placantonakis DG; Lighter J; Galetta S; Balcer L; Melmed KR J Neurol Sci; 2021 Feb; 421():117316. PubMed ID: 33561753 [TBL] [Abstract][Full Text] [Related]
33. Catatonic syndrome as the presentation of encephalitis in association with COVID-19. Vazquez-Guevara D; Badial-Ochoa S; Caceres-Rajo KM; Rodriguez-Leyva I BMJ Case Rep; 2021 Jun; 14(6):. PubMed ID: 34088685 [TBL] [Abstract][Full Text] [Related]
34. [Encephalitis associated with COVID-19 in a 13-year-old girl: A case report]. Conto-Palomino NM; Cabrera-Bueno ML; Vargas-Ponce KG; Rondón-Abuhadba EA; Atamari-Anahui N Medwave; 2020 Aug; 20(7):e7984. PubMed ID: 32804920 [TBL] [Abstract][Full Text] [Related]
35. Autoimmune Encephalitis After SARS-CoV-2 Infection: Case Frequency, Findings, and Outcomes. Valencia Sanchez C; Theel E; Binnicker M; Toledano M; McKeon A Neurology; 2021 Dec; 97(23):e2262-e2268. PubMed ID: 34635560 [TBL] [Abstract][Full Text] [Related]
37. COVID-19's Clinical-Pathological Evidence in Relation to Its Repercussion on the Central and Peripheral Nervous System. Morgado AM; Bezerra ALMS; Felix EBG; Júnior JCS; Pinto NB; Neto MLR; de Aguiar Rocha Martin AL Adv Exp Med Biol; 2021; 1353():197-215. PubMed ID: 35137375 [TBL] [Abstract][Full Text] [Related]
38. Neurological complications in pediatric patients with SARS-CoV-2 infection: a systematic review of the literature. Siracusa L; Cascio A; Giordano S; Medaglia AA; Restivo GA; Pirrone I; Saia GF; Collura F; Colomba C Ital J Pediatr; 2021 Jun; 47(1):123. PubMed ID: 34078441 [TBL] [Abstract][Full Text] [Related]
39. Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Study Design and Rationale. Frontera J; Mainali S; Fink EL; Robertson CL; Schober M; Ziai W; Menon D; Kochanek PM; Suarez JI; Helbok R; McNett M; Chou SH; Neurocrit Care; 2020 Aug; 33(1):25-34. PubMed ID: 32445105 [TBL] [Abstract][Full Text] [Related]
40. Psychosis associated with suspected SARS-CoV-2 encephalitis with response to steroids: a case report. Ariza-Varón M; Beltrán MA; Marín-Medina DS; González AF; Ávila AM Infect Dis (Lond); 2022 Feb; 54(2):152-156. PubMed ID: 34549667 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]